NERV 13F Hedge Fund and Asset Management Owners

Data based on most recent fiscal year report
Market Cap	334.487 Million	Shares Outstanding	39.03 Million	Avg Volume	520.181 Thousand
1-Yr BETA vs S&P TR	1.314	Current Ratio	24.94	Quick Ratio	24.94

Minerva Neurosciences Inc Chart by YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Check out our reporting and analysis

The WhaleWisdom Insider Sell vs Buy Ratio was this bullish twice before: Nov. 2008 and March 2009. Have we seen the Coronavirus bear market bottom?
via whalewisdomalpha 03/25/2020
Netflix Weathers the Storm 03/23/2020
Michael Burry's Scion fund averaged down on battered Tailored Brands. But the passive investing bubble Burry warned about may be bursting.
via whalewisdomalpha 03/22/2020
Did Simon Property insiders signal a bottom in the ravaged REIT sector? 9 directors, including CEO David Simon, bought $20 mil.
via whalewisdomalpha 03/20/2020
Kroger Displays a Steady Rise 03/16/2020
As Coronavirus fears spike and market tanks, Bank Insiders back up the truck to buy.
via whalewisdomalpha 03/13/2020
Top Hedge Funds Pile Into Adobe Ahead of First Quarter Results 03/09/2020
Apple Declines Amid Fears of a Global Pandemic 03/02/2020

Funds Holding NERV (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Click for Additional Filters

Market Value:

Ranking:

% of portfolio

Refresh

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NERV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
DOYLE WILLIAM F EXECUTIVE CHAIRMAN	Officer Director	510,511	2020-03-06	3
LEVINE MARK S. GENERAL COUNSEL	Officer	74,487	2020-03-02	0
LUTHRINGER REMY CEO	Officer Director	0	2019-12-31	2
AHLHOLM FREDERICK W SVP, CHIEF ACCOUNTING OFFICER	Officer	0	2019-12-31	2
RACE GEOFF EVP, CFO & CBO	Officer	0	2019-12-31	2
REILLY JOSEPH H. SVP & CHIEF OPERATING OFFICER	Officer	0	2019-12-31	2
DAVIDSON MICHAEL CHIEF MEDICAL OFFICER	Officer	0	2019-12-31	1
SAOUD JAY SVP AND HEAD OF R&D	Officer	0	2019-12-31	1
RUSSELL RICHARD E. PRESIDENT	Officer	0	2019-12-31	2
SMITH DEVIN WHITTEMORE SVP AND GENERAL COUNSEL	Officer	0	2019-12-31	1
HILLEMAN JERYL L		0	2019-12-03	2
VAN HEEK G JAN	Director	13,333	2019-06-26	2
KUPFER DAVID	Director	247,123	2019-06-26	2
HASLER HANS PETER	Director	10,000	2019-06-26	2
INDEX VENTURE ASSOCIATES III LTD INDEX VENTURE ASSOCIATES IV LTD INDEX VENTURE ASSOCIATES V LTD YUCCA (JERSEY) SLP	10% Owner	3,899,189	2019-06-24	2
LAGHRISSI-THODE FOUZIA	Director	0	2019-05-31	1
JOHNSON & JOHNSON JOHNSON & JOHNSON INNOVATION - JJDC, INC.	10% Owner	No longer subject to file	2018-07-19	0
CARE CAPITAL III LLC CARE CAPITAL INVESTMENTS III L.P. CARE CAPITAL OFFSHORE INVESTMENTS III LP	10% Owner	No longer subject to file	2018-04-18	0
VIVALDI COELHO ROGERIO EVP, CHIEF GLOBAL THERAPEUTICS	Officer	No longer subject to file	2018-03-08	0
BEER MARC D	Director	0	2018-01-31	0
VANDERVELPEN NICO	Director	No longer subject to file	2017-07-24	0
OLLIER MICHELE	Director 10% Owner	4,690,906	2016-12-12	0
DE RUBERTIS FRANCESCO	Director 10% Owner	4,690,906	2016-12-12	0
PELLEGRINI LORENZO	Director 10% Owner	3,883,212	2014-07-07	0

Insider Transactions Last 60 Days

Reporting Owners	Transaction Date	Transaction Code	Shares	Share Price	Acquired or Disposed	Shares Owned Following Transaction	Combined shares owned after filing	Direct/Indirect Ownership	10b-5
No current insider transactions

Minerva Neurosciences Inc (NERV)

Check out our reporting and analysis

Funds Holding NERV (via 13F filings)

Filter by:

Mutual Funds Holding NERV BETA

Active Schedule 13D and 13G filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

Elevate your investments